CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483 | -25.2% | 41,320 | -14.1% | 0.02% | -20.0% |
| Q2 2023 | $646 | -23.6% | 48,075 | -5.7% | 0.02% | -28.6% |
| Q1 2023 | $845 | -11.2% | 50,981 | -0.3% | 0.04% | -16.7% |
| Q4 2022 | $952 | -99.9% | 51,158 | -17.2% | 0.04% | +35.5% |
| Q3 2022 | $793,000 | +45.0% | 61,821 | -20.8% | 0.03% | +93.8% |
| Q2 2022 | $547,000 | -15.3% | 78,019 | +0.2% | 0.02% | +6.7% |
| Q1 2022 | $646,000 | +6.8% | 77,886 | -12.9% | 0.02% | +25.0% |
| Q4 2021 | $605,000 | +28.2% | 89,407 | +0.5% | 0.01% | +9.1% |
| Q3 2021 | $472,000 | -11.6% | 88,990 | -4.1% | 0.01% | +10.0% |
| Q2 2021 | $534,000 | +109.4% | 92,810 | +67.5% | 0.01% | +100.0% |
| Q1 2021 | $255,000 | – | 55,399 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |